Weight-loss jabs linked to lower cancer risk compared with insulin new study
Researchers in the US wanted to know if weight-loss drugs known as GLP-1 agonists reduced the risk of people getting any of the 13 cancers associated with obesity. Their results were recently published in JAMA Network Open.
Source: Medical Xpress
